DUBLIN, Aug. 13, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/xx9ffg/2015_strategies) has announced the addition of the "2015 Strategies in the Global Tumor Marker Testing Market: US, Europe, Japan" report to their offering.
Highlights
Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years.
Examines trends in the U.S., Europe and Japan Reviews current and emerging tumor markers.
Analyzes applications of emerging diagnostic technologies.
Forecasts sales of major tumor markers by country and market segment.
Profiles leading market players and potential entrants
Companies Mentioned:
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca/Nuvelo
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio/Innogenetics
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- Nanogen Elitech
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
For more information visit http://www.researchandmarkets.com/research/xx9ffg/2015_strategies
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
